Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019225 · ClinicalTrials.gov registry record · NA
A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 7,053
- Enrollment target
NCT02019225: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT02019225 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 7,053 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019225, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 7,053 participants
- Enrollment target
Study Summary
The purpose of the TiME Trial is to determine whether dialysis facility implementation of a minimum hemodialysis session duration of 4.25 hours (versus usual care) for patients with end-stage renal disease initiating treatment with thrice weekly maintenance hemodialysis has benefits on mortality, hospitalizations and health-related quality of life. The trial also aims to demonstrate the capacity to conduct a large, pragmatic clinical trial in partnership with two large dialysis provider organizations.
Interventions
- OTHER Dialysis session of at least 4.25 hours
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,053 participants |
| Start Date | 2013-12-18 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019225
The ClinicalTrials.gov registry entry for NCT02019225 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7,053 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dialysis session of at least 4.25 hours is the first listed.
NCT02019225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019225 about?
NCT02019225 is a clinical study titled "A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration". The purpose of the TiME Trial is to determine whether dialysis facility implementation of a minimum hemodialysis session duration of 4.25 hours (versus usual care) for patients with end-stage renal disease initiating treatment with thrice weekly maintenance hemodialysis has benefits on mortality, ho...
What is the current status of trial NCT02019225?
This trial is currently terminated. It is a NA study. The enrollment target is 7,053 participants. The study started on 2013-12-18. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT02019225?
The interventions under investigation include: Dialysis session of at least 4.25 hours (OTHER).
Who is sponsoring clinical trial NCT02019225?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.